VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
March 13 2024 - 8:00AM
Business Wire
VITAS Healthcare Corporation, a wholly-owned subsidiary of
Chemed Corporation (“Chemed”) (NYSE: CHE), announced it entered
into an agreement on March 12, 2024 to acquire all hospice
operations and an assisted living facility from Covenant Health and
Community Services, Inc. d/b/a/ Covenant Care (“Covenant”) for an
aggregate purchase price of $85 million. Covenant’s hospice
operations span the panhandle of Florida and Alabama, specifically
including the Tallahassee, Marianna, Fort Walton Beach, Panama
City, Crestview and Pensacola markets in Florida, and the Dothan
and Mobile/Daphne markets in Alabama.
The transaction is structured as an asset purchase and parties
will seek to close the transaction in the second quarter, subject
to certain regulatory and other approvals.
Nick Westfall, Chairman and CEO of VITAS Healthcare, stated,
“Covenant Care has a 44-year history of providing high-quality,
patient-centered care across communities in Florida and Alabama.
Being a similar long-standing, mission-focused provider, VITAS is
looking forward to building upon their legacy by following our key
values of putting patients, families, and our team members first.
We are excited to welcome the Covenant Care team members who decide
to join our VITAS family as we collectively move forward with
making a difference in all the communities we have the privilege of
serving. I would also like to thank the Covenant Care executive
team and Board of Directors whose vision for how this transaction
will help to fulfill both organizations’ commitment to our missions
led us to this successful announcement today.”
Jeff Mislevy, President and CEO of Covenant Care, stated, “Today
is a monumental day for Covenant Care because it allows the
organization to broaden and deepen its focus on improving
healthcare for the communities we serve by supporting new solutions
and filling gaps in the care delivery system, while at the same
time, keep our promise to the communities by continuing to deliver
the world-class hospice and palliative care they deserve with the
experts at VITAS Healthcare. As a result of the growth, expansion,
and success over the past several years, it became clear that the
organization was well positioned to join forces with a nationally
renowned strategic partner. During this thorough search for the
right provider, it was evident from the beginning that both our
organizations shared an aligned culture, mission, and passion which
led to the Board of Directors unanimously selecting VITAS
Healthcare for this transaction.”
Dr. Rodney Guttmann, Chairman of the Covenant Care Board of
Directors, stated “The Board of Directors is excited for today’s
announcement as it allows us to continue our mission of providing
support for patient care and family grief through existing programs
such as MyWish and Nonie’s Place. Additionally, this allows us to
expand our reach and impact by supporting solutions across the
health care continuum with special focus on behavioral health,
pediatrics, and veteran care.”
Listed on the New York Stock Exchange and headquartered in
Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two
wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS
is the nation's largest provider of end-of-life hospice care and
Roto-Rooter is the nation’s leading provider of plumbing and drain
cleaning services.
Statements in this press release or in other Chemed
communications may relate to future events or Chemed's future
performance. Such statements are forward-looking statements and are
based on present information Chemed has related to its existing
business circumstances. Investors are cautioned that such
forward-looking statements are subject to inherent risk and that
actual results may differ materially from such forward-looking
statements. Further, investors are cautioned that Chemed does not
assume any obligation to update forward-looking statements based on
unanticipated events or changed expectations.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240313721058/en/
Michael D. Witzeman (513) 762-6714
Chemed (NYSE:CHE)
Historical Stock Chart
From Dec 2024 to Jan 2025
Chemed (NYSE:CHE)
Historical Stock Chart
From Jan 2024 to Jan 2025